Stay Updated with the Latest Ulta Beauty, Inc. ULTA News in Real Time
Find ULTA news now at Meyka AI. Stay informed with the latest Ulta Beauty, Inc. stocks updates, including price news, market analysis, and expert insights.
Moonpig (LON: MOON) Shares Jump 10% as FY26 Profit Beats Estimates Under New CEO
Moonpig Group (LON: MOON) delivered a standout performance on June 25, 2026. Shares jumped over 10% after the online greeting card and gifting company reported full-year profit ahead of analyst forecasts. Adjusted earnings per share rose 19.5% the first annual results since CEO Catherine Faiers joined in March. The numbers beat on every key metric:…
Honasa Consumer (NSE: HONASA) Falls 4% to ₹403.50 After ₹135 Crore Fluence Pharma Deal
Honasa Consumer shares fell nearly 4% to ₹403.50 after the company announced its ₹135 crore acquisition of a majority stake in Fluence Pharma in June 2026. The deal marks a major step into India’s fast-growing nutraceutical market, expanding beyond traditional beauty and personal care products. While the stock market reacted cautiously, the move highlights Honasa’s…
Nike Inc (NYSE: NKE) Stock Drops Ahead of Q4 Earnings as Surprise CFO Change Raises Turnaround Questions
Nike Inc chose the worst possible timing for a leadership change. Nike Inc (NYSE: NKE) announced on June 23, 2026, that CFO Matthew Friend will step down effective August 17, to be replaced by David M. Denton as incoming Chief Financial Officer. NKE traded near $45.20 as of June 15, already 44% below its 52-week…
New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%
Global markets faced fresh pressure on June 24, 2026, as a sharp selloff in semiconductor stocks rattled investor sentiment. NVIDIA fell around 4%, while AMD dropped nearly 6%, dragging the Nasdaq Composite down about 2% and the S&P 500 lower by 1%. The weakness also spread to Asia, with New Zealand’s S&P/NZX 50 Index slipping…
Meesho (NSE: MEESHO) Shares Jump 7.3% to ₹184.80 as Citibank Highlights Strategic Edge in E-Commerce Market
Meesho shares gained 7.3% to ₹184.80 on June 23, 2026, after Citibank initiated coverage with a bullish outlook on the company’s future. The move drew strong investor attention and highlighted Meesho’s growing influence in India’s fast-expanding e-commerce market. As online shopping demand continues to rise across smaller cities and towns, analysts see the company benefiting…
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…